The New German Amendment Proposal: Implications for Cannabinoid Companies in the German Market

Picture of Leendert van de Pol

Leendert van de Pol

Leendert is one of our experts in Flowers, Vaping, Vitamines and Hurbs. After more then 40 years of experience in the food industry, Leendert decided to deploy his knowledge and experience as Co-founder at WeeDutch.
All Posts
New Psychoactive Substances Act (NpSG)

Table of Contents

The German Ministry of Health has recently proposed an amendment to the New Psychoactive Substances Act (NpSG), which aims to address the emergence of of psychoactive substances (NPS). This move is set to have significant implications for cannabinoid companies operating in the German market. Let’s delve into the details of the proposal and its potential impact.

Understanding the Amendment Proposal

The core objective of this amendment is to curb the spread and abuse of new psychoactive substances that pose a threat to public health. Due to the rapid evolution and complexity of these substances, the existing regulations under the NpSG are not always sufficient to cover new variants. Thus, the Ministry of Health is continuously updating the substance groups listed in the NpSG annex to include all potentially harmful variants.

Navigating the New Wave The Transition from HHC to 10-OH-HHC in Europe's Evolving Cannabinoid Landscape (1)

Restricted Cannabinoids in the Amendment Proposal

The proposal specifically addresses updates to the controlled substance lists, particularly focusing on synthetic cannabinoids. Here are the main points from the document:

Cannabimimetics/Synthetic Cannabinoids

Expansion of Substance Groups

The list of controlled substances will be expanded to include new synthetic cannabinoids.

Specific Examples Mentioned:

    • Hexahydrocannabinol (HHC): This includes derivatives such as HHC-AC, HHC-H, and HHC-P.
    • Other Synthetic Cannabinoids: Although the text does not mention every synthetic cannabinoid by name, it broadly refers to various new derivatives and analogs of existing synthetic cannabinoids that pose similar health risks.

The proposal also details structural definitions and modifications for identifying these substances, focusing on their chemical properties.

Detailed List from the Admendment

  1. From Indole, Pyrazole, and 4-Quinoline Derived Compounds:

    • Includes compounds with a core structure derived from indole, pyrazole, or 4-quinolone, which are then linked with various side chains and functional groups that influence their psychoactive properties.

  2. Bridging Groups and Side Chains:

    • Specific structural elements such as carbonyl groups, methylene bridges, and various side chains attached at specific positions on the core structures.

  3. Example Structural Modifications:

    • Indole-1,3-diyl and Indazole-1,3-diyl: Compounds with specific substitutions at defined positions.
    • 4-Azaindole and Carbazole: Similar detailed modifications that fit within the defined parameters of psychoactive substances.

Impact on the Market

For German cannabinoid companies, this means that products containing any of these new synthetic cannabinoids or their analogs will be subject to regulation. Companies will need to ensure that their products do not contain these restricted substances to remain compliant with the law.

Compliance Measures

  • Review and Reformulation: Companies should review their product formulations to ensure none of the restricted cannabinoids are present.
  • Quality Control: Implement rigorous quality control measures to detect and prevent the inclusion of banned substances.
  • Stay Updated: Continuously monitor regulatory updates to stay compliant with new laws.

By adhering to these measures, cannabinoid companies can navigate the regulatory landscape effectively while ensuring consumer safety.

10-OH-HHC

Introducing 10-OH-HHC: The Powerful and Safe Cannabinoid for Your Products

Meet 10-OH-HHC, the latest breakthrough in cannabinoids, offering a potent and natural solution for our Germany clients. Ideal for enhancing your oils, vapes, edibles, extracts, and distillates, 10-OH-HHC stands out as a legal and safe option within the German market.

Key Benefits for B2B Clients:

  • Powerful Cannabinoid: 10-OH-HHC is a metabolite of HHC (Hexahydrocannabinol), providing a robust and potent effect.
  • Natural Solution: After ingestion of HHC, it is naturally converted to 10-OH-HHC in the human body.
  • Safety and Legality: Produced by the body itself, 10-OH-HHC is 100% safe and fully compliant with EU regulations.

Why Choose 10-OH-HHC?

  • Versatile Application: Perfect for integration into a variety of products including oils, vapes, edibles, extracts, and distillates.
  • Market Advantage: Offer your customers a cutting-edge cannabinoid that is both powerful and legally compliant.
  • Consumer Confidence: Assure your end-users with a product derived from natural metabolic processes, guaranteeing safety and legality.

Enhance your product line with 10-OH-HHC, the potent and reliable cannabinoid solution. Contact us today to learn more about incorporating this innovative ingredient into your offerings.

Learn more about 10-OH-HHC

Share this post with your colleagues and friends

You may also be interested in ...

You are here: